Autolus Corp (AUTL) Cash Funds per Single Share

Autolus Therapeutics (AUTL) leads the development of programmable CAR-T therapies, which underscores the importance of the cash per share metric illustrated by this chart from the GURU.Markets system. Meanwhile, 0.94 represents the latest level. The company is diversifying its research across various tumor types while maintaining an impeccable reputation and high trust within the global medical community.
Comprehensive metric breakdowns and analytics for Autolus Therapeutics plc (AUTL)

This metric is calculated as the ratio of total cash and cash equivalents to the total number of shares, measuring internal liquidity and the financial safety cushion per share. Analyzing cash per share is critical for Autolus Therapeutics (AUTL), as the capital-intensive deployment of certified cell therapy centers requires significant reserves to navigate stringent regulatory oversight.